Eastman Chemical (EMN) Results Solid, Transformation Continues - BofA/Merrill Lynch

BofA/Merrill Lynch analyst Kevin McCarthy reiterated a Buy rating and $95 price target on Eastman Chemical (NYSE: EMN) following Q3 results with modest upside on the top and bottom-line and guidance to the high end.

The analyst notes management continues to transform Eastman into more of a specialty chemicals company, "Management continues to transform Eastman into more of a specialty chemicals company," he said. He is also attracted to the strong FCF generation (2015 FCF yield 8.2%).

The price target of based on a 12.9x mutlipe to the firm's 2015 EPS estimate of $7.35.

For an analyst ratings summary and ratings history on Eastman Chemical click here. For more ratings news on Eastman Chemical click here.

Shares of Eastman Chemical closed at $75.77 yesterday.

You May Also Be Interested In

• Qualcomm (QCOM) PT Raised to $195 at BofA Securities
• Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink